Quintiles Transitional Holdings Inc. (NYSE:Q)‘s stock had its “hold” rating reissued by equities research analysts at Robert W. Baird in a report issued on Monday. They currently have a $98.00 price objective on the medical research company’s stock. Robert W. Baird’s price target points to a potential upside of 2.40% from the stock’s current price.

Q has been the subject of several other reports. BidaskClub raised shares of Quintiles Transitional Holdings from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 19th. Citigroup Inc. reissued a “neutral” rating and set a $96.00 price target (up from $87.00) on shares of Quintiles Transitional Holdings in a report on Wednesday, June 28th. Royal Bank Of Canada initiated coverage on shares of Quintiles Transitional Holdings in a report on Tuesday, September 19th. They set an “outperform” rating and a $116.00 price target for the company. Argus increased their price target on shares of Quintiles Transitional Holdings from $98.00 to $104.00 and gave the stock a “buy” rating in a report on Monday, September 18th. Finally, Barclays PLC reissued an “overweight” rating and set a $98.00 price target (up from $90.00) on shares of Quintiles Transitional Holdings in a report on Monday, July 17th. Eleven analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Quintiles Transitional Holdings presently has an average rating of “Buy” and an average target price of $93.27.

Shares of Quintiles Transitional Holdings (NYSE Q) traded up 0.26% during trading on Monday, reaching $95.95. The company had a trading volume of 330,816 shares. The firm has a market capitalization of $20.78 billion, a PE ratio of 278.12 and a beta of 0.62. The firm has a 50-day moving average of $95.40 and a 200 day moving average of $88.16. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $99.95.

Quintiles Transitional Holdings (NYSE:Q) last announced its earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The business had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.96 billion. During the same quarter in the prior year, the firm earned $0.93 earnings per share. The business’s quarterly revenue was up 68.7% compared to the same quarter last year. Analysts expect that Quintiles Transitional Holdings will post $4.58 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/09/quintiles-transitional-holdings-inc-q-receives-hold-rating-from-robert-w-baird.html.

In other news, insider Kevin C. Knightly sold 20,000 shares of the stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total value of $1,805,600.00. Following the sale, the insider now directly owns 46,826 shares in the company, valued at $4,227,451.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ari Bousbib sold 46,080 shares of the stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $94.91, for a total transaction of $4,373,452.80. Following the completion of the sale, the insider now owns 1,036,839 shares in the company, valued at $98,406,389.49. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,198,382 shares of company stock valued at $1,361,834,375. 6.40% of the stock is currently owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in the company. UBS Asset Management Americas Inc. boosted its position in Quintiles Transitional Holdings by 4.7% during the first quarter. UBS Asset Management Americas Inc. now owns 400,657 shares of the medical research company’s stock worth $32,265,000 after acquiring an additional 18,040 shares during the last quarter. Prudential Financial Inc. boosted its position in Quintiles Transitional Holdings by 24.6% during the first quarter. Prudential Financial Inc. now owns 18,721 shares of the medical research company’s stock worth $1,508,000 after acquiring an additional 3,700 shares during the last quarter. Credit Agricole S A boosted its position in Quintiles Transitional Holdings by 4.0% during the first quarter. Credit Agricole S A now owns 73,565 shares of the medical research company’s stock worth $5,925,000 after acquiring an additional 2,846 shares during the last quarter. FMR LLC boosted its position in Quintiles Transitional Holdings by 11.2% during the first quarter. FMR LLC now owns 215,936 shares of the medical research company’s stock worth $17,389,000 after acquiring an additional 21,742 shares during the last quarter. Finally, Teachers Advisors LLC boosted its position in Quintiles Transitional Holdings by 23.6% during the first quarter. Teachers Advisors LLC now owns 381,161 shares of the medical research company’s stock worth $30,695,000 after acquiring an additional 72,728 shares during the last quarter. Institutional investors and hedge funds own 93.21% of the company’s stock.

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Stock Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related stocks with our FREE daily email newsletter.